Leap Therapeutics logo

Leap Therapeutics

LPTX | NASDAQ
Chart Builder DCF Calculator
$0.77
-$0.02 (-3.10%)
At close: Apr 01, 2026, 09:30 AM ET
-3.10%

Rating

Updated: Sep 28, 2026
42.5
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $31.86M
1D Range
0.74 0.80
52W Range
0.22 3.58

Valuation (TTM)

PE 1.22
PB 0.23
EV/EBITDA -1.37

Valuation (NTM)

Forward PE 2.65
Forward PEG -0.01
Price Target $5.50
Loading financial charts...

Profile

Leap Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing treatments for various cancers. At the forefront of its pipeline is DKN-01, a monoclonal antibody designed to...

Sector Healthcare
Industry Biotechnology
Employees 52
IPO Date Jan 25, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.